Comparison of sulfasalazine and placebo in the treatment of reactive arthritis (Reiter's syndrome). A department of veterans affairs cooperative study - Concepedia

Concepedia

Publication | Closed Access

Comparison of sulfasalazine and placebo in the treatment of reactive arthritis (Reiter's syndrome). A department of veterans affairs cooperative study

148

Citations

9

References

1996

Year

Daniel O. Clegg, Domenic J. Reda, Michael H. Weisman, John J. Cush, Frank B. Vasey, H. Ralph Schumacher, Elly Budiman‐Mak, Dominic J. Balestra, Warren D. Blackburn, Grant W. Cannon,

Arthritis & Rheumatism

Abstract

SSZ at a dosage of 2,000 mg/day is well tolerated and effective in patients with chronically active ReA.

References

	Year	Citations

Page 1